"FDA approval is many, many years out. Zenith isn't even done their phase 2's."

That may be so, but if a clue of financing for BOM2 comes to fruition it will send RVX share price in a substantially upward direction (and Zenith's) to allow most to trade into a cash position and move on. At least that is what I'm hoping for. I don't think I would want to ride this out beyond that timeline, this go around. Shareholders that built up their holding for both RVX and Zenith at these low prices may do very well in such a scenario. :)  

Koo